Orpea Past Earnings Performance
Past criteria checks 0/6
Orpea's earnings have been declining at an average annual rate of -24.1%, while the Healthcare industry saw earnings growing at 15.3% annually. Revenues have been growing at an average rate of 7.8% per year.
Key information
-24.1%
Earnings growth rate
-24.7%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 7.8% |
| Return on equity | -8.2% |
| Net Margin | -6.8% |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Orpea makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 4,524 | -307 | 0 | 0 |
| 31 Mar 22 | 4,411 | -121 | 0 | 0 |
| 31 Dec 21 | 4,299 | 65 | 0 | 0 |
| 30 Sep 21 | 4,193 | 127 | 0 | 0 |
| 30 Jun 21 | 4,088 | 189 | 0 | 0 |
| 31 Mar 21 | 4,005 | 175 | 0 | 0 |
| 31 Dec 20 | 3,922 | 160 | 0 | 0 |
| 30 Sep 20 | 3,863 | 176 | 0 | 0 |
| 30 Jun 20 | 3,804 | 192 | 0 | 0 |
| 31 Mar 20 | 3,772 | 213 | 0 | 0 |
| 31 Dec 19 | 3,740 | 234 | 0 | 0 |
| 30 Sep 19 | 3,661 | 231 | 0 | 0 |
| 30 Jun 19 | 3,581 | 227 | 0 | 0 |
| 31 Mar 19 | 3,501 | 224 | 0 | 0 |
| 31 Dec 18 | 3,420 | 220 | 0 | 0 |
| 30 Sep 18 | 3,356 | 230 | 0 | 0 |
| 30 Jun 18 | 3,292 | 239 | 0 | 0 |
| 31 Mar 18 | 3,215 | 164 | 0 | 0 |
| 31 Dec 17 | 3,138 | 90 | 0 | 0 |
| 30 Sep 17 | 3,062 | 133 | 0 | 0 |
| 30 Jun 17 | 2,986 | 176 | 0 | 0 |
| 31 Mar 17 | 2,914 | 235 | 0 | 0 |
| 31 Dec 16 | 2,841 | 294 | 0 | 0 |
| 30 Sep 16 | 2,745 | 220 | 0 | 0 |
| 30 Jun 16 | 2,650 | 147 | 0 | 0 |
| 31 Mar 16 | 2,521 | 137 | 0 | 0 |
Quality Earnings: OPA0 is currently unprofitable.
Growing Profit Margin: OPA0 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OPA0 is unprofitable, and losses have increased over the past 5 years at a rate of 24.1% per year.
Accelerating Growth: Unable to compare OPA0's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OPA0 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.1%).
Return on Equity
High ROE: OPA0 has a negative Return on Equity (-8.21%), as it is currently unprofitable.